SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: nihil who wrote (1171)3/13/2000 7:13:00 PM
From: cAPSLOCK  Respond to of 1605
 
As interesting as this may be, it is really silly to focus on it. Perhaps it is a welcome side effect of the treatment, but the obvious benefits EECP gives to heart patients are the important thing, and the company needs to concentrate on getting those machines out there humming.

regards,
cAPSLOCK



To: nihil who wrote (1171)3/17/2000 1:04:00 AM
From: Jacques Tenzel  Read Replies (1) | Respond to of 1605
 
Does anyone know what the Medicare reimbursement for a one hour EECP treatment is? Basically in these times of competing treatments, the acceptance of this technology by the practicing cardiologists will be determined as much by the business aspects of the decision of whether to purchase a $200,000 machine as by the pure medical benefits to the patient.
Thanks for the help.

Happy Investing......Jacques


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News